Based on the estrogen receptor (ER), progesterone receptor and human epidermal growth factor receptor-2 (HER2) status, there are three breast cancer subtypes: HER2-positive, hormone receptor-positive and triple negative subtypes (Parise and Caggiano, 2014). Here, ESR1 is linked to breast carcinoma.